Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Submitted by
admin
on October 24, 2017 - 9:10am
Source:
Endpoints
News Tags:
AbbVie
Alzheimer's disease
Alector
R&D
Headline:
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Do Not Allow Advertisers to Use My Personal information
